Encompass Health (EHC)
(Delayed Data from NYSE)
$94.50 USD
-0.23 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$94.50 USD
-0.23 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Zacks News
Encompass Health (EHC) Set to Widen Presence in South Carolina
by Zacks Equity Research
Encompass Health (EHC) reveals plans to construct a 27-bed hospital in South Carolina aimed at providing high-quality rehabilitative care throughout the state.
Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's
by Zacks Equity Research
Zacks.com featured highlights include: Celestica, Encompass Health, Atlas Corp, DXC Technology and Conn's
Pick These 5 Low P/CF Stocks to Garner Superior Returns
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Celestica (CLS), Encompass Health (EHC), Atlas (ATCO), DXC Technology (DXC) and Conn's (CONN) boast low P/CF ratio.
Encompass Health (EHC) Misses on Q3 Earnings, Cuts '21 EPS View
by Zacks Equity Research
Encompass Health's (EHC) third-quarter earnings miss estimates but improve year over year on the back of top-line growth resulting from a sound Inpatient Rehabilitation segment.
Encompass Health (EHC) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of -3.74% and -2.38%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Encompass Health (EHC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
by Zacks Equity Research
Zacks.com featured highlights include: Foot Locker, Hibbett, Group 1 Automotive, Teck Resources and Encompass Health
Buy These 7 Best Value Stocks to Make the Most of P/B Ratio
by Kinjel Shah
P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects.
Walgreens (WBA) to Make Additional Investment in VillageMD
by Zacks Equity Research
Walgreens (WBA) announced a $5.2-billion investment in VillageMD to bolster its strategic position in delivering value-based primary care.
Encompass Health (EHC) Rides on Solid Revenues, Expansion Plans
by Zacks Equity Research
Encompass Health (EHC) continues to gain, courtesy of sustained growth in revenues, sound expansion endeavors across the United States and a robust 2021 business outlook.
LHC Group (LHCG) Finalizes Home Health & Hospice Buyout Deals
by Zacks Equity Research
LHC Group (LHCG) to expand in Virginia Beach with the completion of the previously announced acquisition agreements with two providers, one in home health and the other in hospice.
Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group
by Zacks Equity Research
Zacks.com featured highlights include: Hibbett, Encompass Health, Berry Global Group, Vishay Intertechnology and Affiliated Managers Group
Pick These 5 Low P/CF Stocks for a Value-Based Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Hibbett (HIBB), Encompass Health (EHC), Berry Global (BERY), Vishay Intertechnology (VSH) and Affiliated Managers (AMG) boast low P/CF ratio.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth (UNH) Unit Ties Up to Offer Quality Care in Midwest
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum collaborates with SSM Health in a bid to employ advanced technologies and insights for delivering better health outcomes across the Midwest.
EHC or AMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. AMED: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics
3 Top Stocks From the Buoyant Outpatient Home Health Industry
by Trina Mukherjee
Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and USPH are well-poised to gain from the prospects.
Pick These 5 Low P/CF Stocks for a Balanced Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Boise Cascade (BCC), Encompass Health (EHC), Hibbett (HIBB), Celestica (CLS) and Flex Ltd. (FLEX) boast low P/CF ratio.
New Strong Buy Stocks for September 21st
by Zacks Equity Research
CASY, DSKE, EHC, GIII, and STRL have been added to the Zacks Rank #1 (Strong Buy) List on September 21, 2021.
What Makes Encompass Health (EHC) a New Strong Buy Stock
by Zacks Equity Research
Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
EHC or AMED: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. AMED: Which Stock Is the Better Value Option?
HealthEquity (HQY) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) witnesses solid growth in HSAs and records robust Interchange revenues in the second quarter of fiscal 2022.
3 MedTech Sectors Benefiting Despite COVID-19 Resurgence
by Urmimala Biswas
Here we discuss three major subsectors of MedTech and some of their constituent stocks for which COVID-19 has opened up enormous growth prospects.